ARCT: Arcturus Therapeutics Holdings Inc. - Summary | Jitta
Jitta Wealth
NEW
Log in
Sign up
×
Log in

Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

SummaryFactSheetFinancial
Price
$7.03
Loss Chance
58.3%
0.01JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Biotechnology
277 / 278
Health Care
714 / 715
United States
?
4,198 / 4,217
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Related
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.22
39.14%
Aurinia Pharmaceuticals
NASDAQ:AUPH
5.68
$15.22
39.14%
Catalyst Pharmaceuticals
NASDAQ:CPRX
6.36
$31.26
42.69%
Exelixis
NASDAQ:EXEL
6.93
$50.15
32.12%
Fabien Corp.
NASDAQ:FBIO
1.90
$0.13
100.00%
Jitta Factors
Growth Opportunity (4)
Recent Business Performance (19)
Financial Strength (30)
Return to Shareholders (3)
Competitive Advantage (10)
Jitta Signs
Cash Conversion CycleLess than 60 days
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 191.37% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
0.01
100.00%
2.22
139.24%
3.06
206.98%
Biotechnology
5.68
39.14%
5.68
39.14%
6.36
42.69%
COMPANY DESCRIPTION
Arcturus Therapeutics Holdings Inc., a messenger RNA medicines company, focuses on the development of liver and respiratory rare disease therapeutics. Its technology platforms include STARR, a self-amplifying mRNA technology platform, and LUNAR, a lipid-mediated delivery system. The company also develops ARCT-032 (LUNAR-CF), an mRNA therapeutic candidate for cystic fibrosis that is in Phase 2 clinical development; and ARCT-810 (LUNAR-OTC), which is in Phase 2 clinical development to address ornithine transcarbamylase (OTC) deficiency. In addition, it develops KOSTAIVE, a self-amplifying RNA vaccine for COVID-19; ARCT-2138 (LUNAR-FLU), which is in Phase1 clinical trial for the treatment of seasonal influenza; and ARCT-2304 (LUNAR-H5N1) that is in Phase1 clinical trial for the treatment of Pandemic Influenza. Arcturus Therapeutics Holdings Inc. was founded in 2013 and is headquartered in San Diego, California.
arcturusrx.com
About UsCareersHelp CenterLibraryTermsPrivacyContact UsPress

Jitta Dot Com Co., Ltd. is the owner of the copyright of JITTA SCORE, JITTA LINE, JITTA SIGNS, JITTA FACTORS, JITTA LOSS CHANCE and JITTA RANKING. By accessing or using Jitta, you agree to comply with our Terms of Use and agree not to redistribute the information.

All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Any historical returns, backtest statistics or probability projections may not reflect future performance. Neither Jitta nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Fundamental data of companies, historical data, daily updates, financial statements, dividend data and index data are provided by S&P Global Market Intelligence. All stock prices are updated at the end of the day.